Internal Medicine Alert – February 15, 2013
February 15, 2013
View Issues
-
Does Persistent Subclinical Hypothyroidism Put the Elderly at Cardiovascular Risk?
In older adults, no association was found between subclinical hypothyroidism and coronary heart disease, heart failure, and cardiovascular mortality. -
Mortality Risk Associated with Electrocardiographic Bundle Branch Blocks in Women
Prevalent left bundle branch block (LBBB) in cardiovascular disease (CVD)-free women and either LBBB or right bundle branch block (RBBB) in women with CVD were significant predictors of coronary heart disease (CHD) death. In women with LBBB, ST segment J-point depression in lead aVL was also a strong independent predictor of CHD death. -
An Increased Risk of Non-Hodgkin Lymphoma in Chronic Fatigue Syndrome Patients
Chronic fatigue syndrome (CFS) is common in community practice and it has been speculated that it is the result of chronic immune proliferation or infection. In a review of Surveillance, Epidemiology, and End Results registry data, coupled with Medicare claims data, an association of CFS with non-Hodgkin lymphoma is clearly demonstrated. -
Pharmacology Update: Sodium Picosulfate, Magnesium Oxide, and Citric Acid (Prepopik)
A colonic cleansing preparation has been approved by the FDA. The preparation contains sodium picosulfate, magnesium oxide, and citric acid and forms sodium picosulfate and magnesium citrate upon reconstitution (PSMC). The preparation has been available outside the United States since 1980 and is manufactured and marketed by Ferring Pharmaceuticals as Prepopik. -
Clinical Briefs By Louis Kuritzky, MD
When One Antihypertensive Med is Not Enough: Which Combination?; Early Identification of COPD Exacerbations; Vitamin D for Osteoarthritis: NOT -
ECG Review: Chest Pain and Two Key ECG Findings
The 12-lead ECG shown above was obtained from a 50-year-old woman with chest pain. What two major conclusions should be reached regarding ECG interpretation of this tracing? -
Pharmacology Watch: FDA Approves Apixaban for Patients with Nonvalvular AF
Apixaban approval; new dental clinical practice guideline; apixaban for VTE; aspirin resistance; tamoxifen treatment; and FDA actions.